Excess risk of primary liver cancer in patients with diabetes mellitus.

Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 3.34

The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis (2011) 2.96

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90

Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer (2009) 2.19

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One (2013) 2.10

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer (2010) 2.04

Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer (2005) 1.52

Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol (2006) 1.25

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol (2014) 1.12

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol (2008) 1.12

Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09

Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control (2012) 1.04

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer (2013) 1.03

Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr (1997) 1.00

Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection. J Clin Exp Hepatol (2013) 0.98

Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98

Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. J Gastroenterol (2012) 0.96

Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes. Proc Natl Acad Sci U S A (2007) 0.95

Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer (2010) 0.94

Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ Health Perspect (2006) 0.94

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol (2013) 0.94

Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes. Oncotarget (2014) 0.92

Diabetes and risk of renal cell carcinoma. J Cancer (2011) 0.91

Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol (2009) 0.89

Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol (2010) 0.89

Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol (1998) 0.89

Human variability and susceptibility to trichloroethylene. Environ Health Perspect (2000) 0.88

Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Ann Saudi Med (2010) 0.87

Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control (2012) 0.87

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy. J Gastroenterol (2011) 0.87

Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. PLoS One (2013) 0.86

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Carcinogenesis (2011) 0.86

Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver (2009) 0.85

Alcohol and breast cancer risk: the alcoholism paradox. Br J Cancer (2000) 0.84

Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis (2011) 0.84

Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease. Curr Mol Med (2010) 0.84

Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes. Br J Cancer (2014) 0.83

Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis. Am J Gastroenterol (2016) 0.82

Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol (2016) 0.82

The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. J Clin Imaging Sci (2015) 0.82

Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation. Am J Cancer Res (2015) 0.81

Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol (2010) 0.80

The association between paternal prostate cancer and type 2 diabetes. J Carcinog (2007) 0.80

Re: Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1997) 0.79

Recent insights on risk factors of hepatocellular carcinoma. World J Hepatol (2009) 0.79

Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma. Dig Dis Sci (2006) 0.79

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus. Hepat Med (2011) 0.78

Lipogenic metabolism: a viable target for prostate cancer treatment? Asian J Androl (2014) 0.78

Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepatol (2015) 0.78

The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma. Gastroenterol Res Pract (2011) 0.78

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B. Clin Mol Hepatol (2016) 0.78

Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma. BMC Gastroenterol (2013) 0.78

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol (2016) 0.77

Surveillance for Hepatocellular Carcinoma in Patients with NASH. Diagnostics (Basel) (2016) 0.77

Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis. Prz Gastroenterol (2015) 0.76

Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. World J Gastroenterol (2003) 0.76

Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes. PLoS One (2016) 0.76

Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience. Int J Surg Oncol (2012) 0.76

Dietary sugar intake increases liver tumor incidence in female mice. Sci Rep (2016) 0.75

Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma. World J Hepatol (2016) 0.75

Microarray profile of human kidney from diabetes, renal cell carcinoma and renal cell carcinoma with diabetes. Genes Cancer (2015) 0.75

Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol (2016) 0.75

Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma. Exp Ther Med (2010) 0.75

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol (2017) 0.75

Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open (2017) 0.75

Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis. Int J Clin Oncol (2015) 0.75

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68

Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57

Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96

Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54

Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol (1989) 6.46

A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39

Effect of adenosine on atrioventricular (AV) conduction. Pacing Clin Electrophysiol (1990) 5.83

Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65

Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33

Current status of clinical islet transplantation. Transplantation (2005) 4.17

Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09

Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08

Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86

Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80

Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66

Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63

Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57

Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther (2012) 3.57

Sickness in pregnancy and sex of child. Lancet (1999) 3.48

Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37

Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34

Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31

Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30

Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28

Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22

Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17

Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13

A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13

Appendectomy and protection against ulcerative colitis. N Engl J Med (2001) 3.06

Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05

Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00

Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98

Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis (2005) 2.93

Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia (2006) 2.91

Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88

Selection of controls in case-control studies. III. Design options. Am J Epidemiol (1992) 2.88

Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88

Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med (1989) 2.79

Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76

Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76

Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68

Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66

Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65

The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65

Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64

Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64

Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64

A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59

The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58

The impact of endoscopists' experience and learning curves and interendoscopist variation on colonoscopy completion rates. Endoscopy (2001) 2.55

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55

Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia (2007) 2.54

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51

Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51

Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50

International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50

Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol (1987) 2.49

Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49

Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45